IMCC - IM Cannabis Corp.
IEX Last Trade
2.27
0.160 7.048%
Share volume: 0
Last Updated: Thu 26 Dec 2024 03:24:27 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$2.11
0.16
7.58%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
6.25%
1 Month
-14.67%
3 Months
-1.78%
6 Months
360.42%
1 Year
550.29%
2 Year
110.48%
Key data
Stock price
$2.27
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.23 - $4.49
52 WEEK CHANGE
$557.35
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/11/2024
Company detail
CEO: Oren Shuster
Region: US
Website: imcannabis.com
Employees: 340
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: imcannabis.com
Employees: 340
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
IM Cannabis Corp. engages in breeding, growing, and supply medical cannabis products. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers.
Recent news